M.D. Anderson Cancer Center: Communicable Diseases trials

The registry lists 10 Communicable Diseases studies with M.D. Anderson Cancer Center as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 1Phase 2 7Phase 3 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-TazobactamCompletedNCT03485950Phase 2Results posted
• Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT02530515Phase 2Results posted
• Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)TerminatedNCT01821963Phase 3Results posted
• Respiratory Syncytial Virus - RSV ProtocolCompletedNCT01502072Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer PatientsCompletedNCT01321879Phase 2Results posted
• Catheter Related - Gram Positive Bloodstream InfectionsCompletedNCT00467272Phase 2Results posted
• Widespread vs. Selective Screening for Hepatitis B Infection Prior to ChemotherapyCompletedNCT01970254
• Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)CompletedNCT01539343Phase 2
• Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
• Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV InfectionCompletedNCT00508170